PB Ratio of Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd
NSE: PAR
PB Ratio
Key Highlights
- The latest PB Ratio of Par Drugs & Chemicals Ltd is 1.4.
- The PB ratio of the Par Drugs & Chemicals Ltd is below 1.5 which indicates that the stock is fairly valued The P/B Ratio of Par Drugs & Chemicals Ltd changed from 1.5 on March 2021 to 0.9 on March 2026 . This represents a CAGR of -8.16% over 6 years .
Historical P/B Ratio of Par Drugs & Chemicals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Par Drugs & Chemicals Ltd
Company Fundamentals for Par Drugs & Chemicals Ltd
Market Price of Par Drugs & Chemicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 122.74 |
| 05 Oct 2026 | 125.79 |
| 01 Oct 2026 | 123.95 |
| 30 Sep 2026 | 126.64 |
| 29 Sep 2026 | 125.32 |
| 28 Sep 2026 | 130.05 |
| 25 Sep 2026 | 131.41 |
| 24 Sep 2026 | 131.31 |
| 23 Sep 2026 | 131.92 |
| 22 Sep 2026 | 137.82 |
SWOT Analysis Of Par Drugs & Chemicals Ltd
BlinkX Score for Par Drugs & Chemicals Ltd
Asset Value vs Market Value of Par Drugs & Chemicals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Par Drugs & Chemicals Ltd | 1.38 | 154.78 |
| Sun Pharmaceutical Industries Ltd | 94.2 | 427562 |
| Divis Laboratories Ltd | 652.2 | 244572 |
| Torrent Pharmaceuticals Ltd | 223.8 | 180871 |
| Zydus Lifesciences Ltd | 241.8 | 113566 |
PB Ratio of Par Drugs & Chemicals Ltd Explained
₹154.78
Market cap
₹91
Book Value per Share
1.4X
PB Ratio
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Par Drugs & Chemicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Par Drugs & Chemicals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Par Drugs & Chemicals Ltd News Hub
Par Drugs & Chemicals AGM scheduled
Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he
Read more
19 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024
Read more
10 Aug 24
Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter
Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag
Read more
05 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202
Read more
14 Oct 24
